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Molecular dockingNeuromyelitis optica (NMO) is a multiple sclerosis-like immunopathology disease affecting optic nerves and the
spinal cord. Its pathological hallmark is the deposition of a typical immunoglobulin, called NMO-IgG, against the
water channel Aquaporin-4 (AQP4). PreventingNMO-IgG bindingwould represent a valuablemolecular strategy
for a focused NMO therapy. The recent observation that aspartate in position 69 (D69) is determinant for the
formation of NMO-IgG epitopes prompted us to carry out intensiveMolecular Dynamics (MD) studies on a num-
ber of single-point AQP4 mutants. Here, we report a domino effect originating from the point mutation at posi-
tion 69: we ﬁnd that the side chain of T62 is reoriented far from its expected position leaning on the lumen of
the pore. More importantly, the strength of the H-bond interaction between L53 and T56, at the basis of the
loop A, is substantially weakened. These events represent important pieces of a clear-cut mechanistic rationale
behind the failure of the NMO-IgG binding, while the water channel function as well as the propensity to aggre-
gate into OAPs remains unaltered. The molecular interaction ﬁelds (MIF)-based analysis of cavities
complementedMDﬁndings indicating a putative binding site comprising the same residues determining epitope
reorganization. In this respect, docking studies unveiled an intriguing perspective to address the future design of
small drug-like compounds against NMO. In agreementwith recent experimental observations, the present study
is the ﬁrst computational attempt to elucidate NMO-IgG binding at the molecular level, as well as a ﬁrst effort to-
ward a less elusive AQP4 druggability.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
As a family of pore-formingmembrane proteins, aquaporins (AQPs)
allow the fast and selective ﬂux of water and other small solutes
through biological membranes [1–6]. Among the 13 homologous aqua-
porins identiﬁed so far, Aquaporin-4 (AQP4) has attracted increasing
interest in the last years. Indeed, it plays a critical role in deafness [7,
8], in the formation of brain edema [9,10] and is the target antigen of
IgG autoantibodies in the neuroinﬂammatory demyelinating disease
Neuromyelitis Optica (NMO) [11,12], a multiple sclerosis-like disorder
that predominantly features immunopathology in the optic nerves
and the spinal cord [13]. The binding of serum autoantibody (NMO-
IgG) to AQP4 enhances the perivascular inﬂammation characteristic of
NMO and induces breakdown of the blood–brain barrier. The presence.of NMO-IgG against AQP4 is presently considered a signal for the
onset of NMO, being detected in about 75% of patients showing such a
disabling disorder [13]. AQP4 is expressed at the plasma membrane
in astrocytes, in the central nervous system, and in various peripheral
organs such as skeletal muscle and kidney [14,15]. From a structural
point of view, it is characterized by six transmembrane helices forming
a water selective pore in the center of the molecule [16].
Two different human isoforms of AQP4 have been identiﬁed so far,
namelyM1 (32 kDa) andM23 (30 kDa). They share identical extracellu-
lar domain residues but M1 comprises 22 more amino acids at the
cytoplasmatic N terminus [17,18]. These isoforms are organized in the
membrane as heterotetramers, which can, in turn, aggregate to form
structures known as Orthogonal Arrays of Particles (OAPs) of different
sizes [19–23]. Notably, M23 is the OAP-forming isoform while it has
been observed that a homotetramer of M1 is unable to form OAPs. In
other words, variously sized OAPs can be observed depending on the
ratio at which the two isoforms are expressed [20]. Importantly, it has
been shown that conformational changes at the level of the extracellular
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molecular conformation [24].
In this respect, a coauthored recent work [25] has shown that the
mutation of an aspartate in position 69 (D69) impairs the binding
between AQP4 and NMO-IgG leaving the water channel function unal-
tered as well as the formation of the OAPs. Based on 20 ns MD simula-
tions, we speculated that the replacement of D69 with a histidine was
responsible for an increased mobility of loop A, with the consequent
disruption of the conformational epitopes. Building on this hypothesis,
in the present work we have extended the previous MD simulations
to 100 ns-long trajectories for the AQP4 tetramer of wild type (WT)
and each mutated form (MT). The longer simulation time allowed us
to identify the reorientation of the side chain of T62 as a key element
for epitope recognition and thus for NMO-IgG binding. In recent years
molecular dynamics (MD) simulations proved effective to obtain im-
portant structural and mechanistic insights into the water transport of
aquaporins [26–33]. Here, we employ the same technique to obtain
some insight on NMO-IgG epitope reorganization. In addition, the
need to elucidate the druggability of AQP4 has prompted us to use the
GRID molecular interactions ﬁelds (MIFs) [34]. We have sampled the
AQP4 surface in the search for appropriately sized cavities acting as
putative binding sites for protein–ligand recognition. In particular, the
AQP4 druggability has been assessed with respect to known targetable
proteins. Finally, induced ﬁt docking simulations were successfully
carried out on three compounds that are, to date, the only ones demon-
strating an appreciable inhibition of NMO-IgG binding to AQP4 in NMO
patient sera.2. Materials and methods
2.1. From X-ray structure to model system preparation
The starting structure of AQP4 was obtained from the Protein Data
Bank (PDB), entry 3GD8 [16]. The obtained crystal was ﬁrst pretreated
using the protein preparation module available from the Schrödinger
Suite 2013 [35] which enables to add missing hydrogen atoms and
to determine the optimal protonation states for histidine residues. The
simulation system was built as follows. A 120 × 120 Å [2] POPC (1-
palmitoyl,2-oleoyl-sn-glycero-3-phosphocholine) bilayer patch was
ﬁrst built using the membrane plugin of VMD (Visual Molecular
Dynamics) [36], with the membrane normal along the z-axis. A tetra-
mer of AQP4 was then embedded in this bilayer and lipid molecules
within 0.8 Å of heavy atoms of the protein were removed. To neutralize
the system, 23 Na+ and 19 Cl− ions were added using the VMD's
“autoionize” plugin, generating a 100 mM ionic concentration and a
ﬁnal system of 135,833 atoms (number computed forWT). Bothmutat-
ed and WT protein structures were incorporated into a periodic box of
TIP3P water molecules [37] extended by 18 Å in each direction from
all protein atoms using the “solvate” plugin of VMD. In the D69Hmutat-
ed protein, two tautomeric states for histidine are possible. In the ﬁrst
(D69HSD), the hydrogen atom is bonded to the carbon δ of H69, while
in the second (D69HSE) the hydrogen atom is bonded to the carbon ε
of H69. In our investigation, the tautomeric state of histidine 69 was
univocally assigned on the basis of the hydrogen bond network predict-
able from the X-ray of AQP0 (PDB codes 1YMG and 2B6P). Indeed, this
was the rationale inspiring the mutations at position 69 [25] since
NMO-IgGs did not recognize chimeras made by AQP0 transmembrane
domains [24]. The pretreatment of such crystals using the protein prep-
arationmodule available from the Schrödinger Suite 2013 [35] returned
hydrogen bonded to carbon δ of H69. So, hereafter D69H will indicate a
mutation involvinghydrogen bonded to carbon δofH69. However, since
tautomers can interconvert under physiological conditions and play
very different actions, we decided to build also the D69HSE system, as
a controlMD simulation. The obtained data are shown in the Supporting
Information (Fig. S1).2.2. Molecular dynamics simulations
All MD simulations were performed using NAMD 2.9 [38] and the
CHARMM27 force ﬁeld [39]. The full system was minimized to remove
steric clashes in the initial geometry and gradually heated up to 310 K
within 500 ps of MD. The SHAKE algorithm was employed to constrain
all R\H bonds. Periodic boundary conditions were applied in all
directions. A non-bonded cut-off of 12 Å was used, whereas the
Particle-Mesh-Ewald (PME) [40] was employed to include the con-
tributions of long-range interactions. All simulations were performed
in an isothermal–isobaric ensemble (1 atm, 310 K)with a Nosè–Hoover
Langevin barostat [41,42] (oscillation period 200 fs, decay coefﬁcient
100 fs) and a Langevin thermostat [43] (damping coefﬁcient 1 ps−1).
The time step was set to 2 fs, and coordinates were saved every 1000
steps (2 ps). For all the considered systems, the equilibration of the
structure required less than 5 ns and, thus, the ﬁrst 5 ns were removed
from the analysis of the obtained 100 ns of trajectory. All simulations
were performed on the FERMI supercomputer at CINECA, Italy.
2.3. Calculation of the osmotic permeability
The osmotic permeability (pf) matrix was calculated in the frame-
work of the theory proposed by Zhu et al. [44] The trajectory was
subdivided in time intervals of 5 ns each, and the pf was calculated for
each monomer and each time interval.
The ﬁrst step consisted in the computation of the variable dn:
dn ¼
X
i∈ S tð Þ
dzi=L
where dzi is the displacement of the water molecule i along the z direc-
tion within the time interval dt and S(t) is the set of water molecules
inside the channel of length L at time t.
Considering n(t) as the integral of dn over time, the total diffusion
coefﬁcient Dn is given by the mean-square displacement as follows:
n2 tð Þ
D E
¼ 2Dnt þ C
where C is a constant.
Finally the osmotic permeability was computed as:
P f ¼ vWDn
where, vw is the average volume occupied by a single water molecule.
2.4. Identiﬁcation of cavities
The FLAPsite [45–47] algorithm was used for the identiﬁcation of
cavities within the AQP4 crystal structure (PDB entry: 3GD8). The pro-
cedure started by embedding the target protein into a gridwith a spatial
resolution of 1.0 Å. Two GRID [34] probes were used by the detection
routine: the GRID [34] H probe (shape) to identify pocket points and
the DRY probe (hydrophobic) for buriedness calculation prioritizing
hydrophobic cavities. Once all pockets points were identiﬁed by H
probe, the next step focused on grid points located within a distance
of 4 Å from the closest protein atom, excluding protein surface points.
For the remaining points, a buriedness-index was calculated. The
buriedness-index was also weighted by the hydrophobicity computed
using the GRID hydrophobic DRY probe. Points with a buriedness-
index lower than a pre-determined threshold were discarded. The
remaining points were processed by two morphological operations,
namely erosion to remove small anomalies (decreasing the size of the
cavity) and dilation to ﬁll holes and connect areas (increasing the size
of the cavity). By using the GRID hydrophobic probe (DRY), hydrophobic
interactions were calculated for each cavity. Cavities showing favorable
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molecules.
2.5. Druggability assessment
We collected a reference dataset containing 43 target structures
deﬁned as ‘druggable’ by Cheng et al. [48] The cavities for each target
were detected by the FLAPsite tool [45,46]. Volsurf [49,50] descriptors
were used to characterize either the AQP4 cavity close to the loop A or
each pocket in the reference druggable target dataset. Volume, surface,
rugosity, globularity, hydrophobicity, hydrophilicity and charged resi-
dues descriptors were calculated. Pocket volume and surface represent
the water-excluded volume and the accessible surface respectively,
traced out by the GRID OH2 probe (water probe). Rugosity and
globularity represent the presence of wrinkles or creases on the pocket
surface and the degree of sphericity of the pocket, respectively. Hydro-
phobicity and hydrophilicity were quantiﬁed using the GRID probes
DRY and OH2 respectively. The hydrophobic probe is used to mimic
the pocket attractive hydrophobic interactions, while the water probe
is used to mimic solvation–desolvation processes. GRID probes N1+
and O− are instead suitable probes used to detect charge–charge elec-
trostatic interactions but also polar interactions generated by pocket
residues. A comparative analysis of the AQP4 cavity against the well-
known druggable active sites reference dataset was performed by plot-
ting distributions of the corresponding chemical–physical properties.
2.6. Docking studies
Flexible receptor docking studies were performed using a multi-
stage induced ﬁt docking protocol (IFD) available from the Schrödinger
Suite 2013 [35]. A cubic docking grid centered on the centroid of resi-
dues T62, D69 and T56 and having a side equal to 26 Å was used. In
the ﬁrst stage, the van der Waals radii of the protein and the ligand
were scaled by a factor of 0.5 and ligands were docked using the default
Glide SP mode. Subsequently, prime was used to predict and optimize
the selected protein side chains. The poses were scored and ﬁltered,
and ﬁnally ligands were redocked using the Glide SP mode and scored.
3. Results
All results shown in the present sectionwere obtained analyzing the
calculated MD trajectories (95 ns at 310 K after 5 ns of equilibration for
each considered system). Beyond the wild type (WT), three differentFig. 1. Sketches of the residues involved in the considered mutations. Note that D69 anengineeredmutants were investigated: D69E, D69H andM70V. The latter
was employed as a negative control, since such mutation is known not
to affect the NMO-IgG epitope unlike the other MTs [25]. A synoptic
view is reported in Fig. 1.
First, we report the analysis of distances of alpha carbon atoms aver-
aged among the four monomers (C-alphaAV) in order to investigate the
occurrence of possible conformational changes in the nearby of the con-
sideredmutations. Second, we analyze the differences betweenWT and
MTs in terms of H-bond interactions during the simulation. Third, we
show the obtained osmotic permeabilities for theWTand all the consid-
ered MTs. Fourth, we describe the predicted AQP4 cavity, pointing out
its putative role as a binding site.3.1. C-alphaAV distances
As shown in Fig. 2, the AQP4 tetramer is axially-symmetric with re-
spect to the z-axis passing through the center of the system. As a result,
the distances of a given residue in the 4 monomers from the z-axis are
expected to be almost equal. Keeping this in mind, the global effect of
the mutations was evaluated by averaging data over the four mono-
mers. In particular, the distance between the C-alpha of a given residue
in a givenmonomer vs. its specular symmetric (i.e.monomer A vs. B and
monomer C vs. D, see Fig. 2) was computed. A value averaged along the
obtainedMD trajectorywas considered for both occurrences (monomer
A vs.monomer B andmonomer C vs.monomerD, see Fig. 2). Finally, the
two obtained values were further averaged in order to have a single
parameter for each residue, hereafter named C-alphaAV.
As shown in Fig. 3a, C-alphaAV distances for all MTs and the WT do
overlap over the entire protein sequence, including the extracellular
loops. Interestingly, an exception is represented by few residues just
upstream the mutation, in particular from residue G60 to residue L66,
a region that is part of the extracellular loop A. This becomes even
clearer in Fig. 3b where a zoomed view is shown. The uncertainties
related to C-alpha distances were calculated by the block averaging
method (see the section “statistical analysis” in the supporting informa-
tion for details). In particular, threonine at position 62 (hereafter
referred to as T62) is the residue showing the largest difference when
comparing C-alphaAV of WT and MTs. In other words, the computed
C-alphaAV values suggest a sort of “domino effect” [51] where the substi-
tution of a single residue in position 69 induces a substantial modiﬁca-
tion of the conformation of other residues upstream the mutation.
Focusing our attention on residue T62, the CalphaAV values closest to
WT (31.37 ± 0.66 Å) are exhibited by D69E (31.39 ± 1.73 Å) and M70Vd M70 are the ﬁrst residues of the trans-membrane region downstream of loop A.
Fig. 2. a) Top view and b) lateral view of the investigated systems. Water molecules and the membrane bilayer are rendered as sticks while the AQP4 tetramer is shown in cartoon
representation.
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(34.73 ± 0.47 Å), being such CalphaAV value N 3 Å compared to WT.
Such trend, based on averaged values, is also conﬁrmed when the two
computed C-alpha distances (monomer A vs. B and monomer C vs.
D) are considered separately. Regarding residue T62, for instance, both
data for WT (29.86 ± 0.54 and 32.88 ± 0.38) are lower than those ob-
tained for D69H (35.22 ± 0.36 and 34.24 ± 0.30). The reported error
bars clearly demonstrate the statistical signiﬁcance of the observed dif-
ferences. These ﬁndings are in agreement with our recent work [25]
where we ﬁrst hypothesized that the effect of the point mutation in
69 is transferred to residues upstream the mutation, including T62.
We do not report signiﬁcant differences in the C-alphaAV distancesFig. 3. a) C-alphaAV values (Å) computed for all residues of the investigated systems.
b) Zoomed ﬁgure showing C-alphaAV data and corresponding error bars (Å) computed
for residues belonging to a portion of loop A (from residue G60 to residue L66).between WT and D69E. However this does not imply that the D69E
mutation has no effect, as will be explained below.
As shown in Fig. 4a, data taken from the trajectory of WT display a
Gaussian distribution. In particular, most of the obtained MD snapshots
show C-alpha distances in a range of 30–34 Å. The distribution function
computed for the D69Emutant provided awealth of additional informa-
tion with respect to the mere analysis of the C-alphaAV. Despite the fact
that C-alphaAV values computed for T62 of WT and D69E are almost
equal, their corresponding distribution functions are strongly different.
In fact, a bimodal distribution can be detected only for D69E thus indicat-
ing the occurrence of two dominant conformational states. The ﬁrst one
(hereafter referred to as D69E(1)), missing in WT, discloses a peak
around 21 Å whereas the second one (D69E(2)) is shifted to larger
values (peak around 36 Å) with respect to WT. More importantly, this
second and more populated state shows a nice overlap with that of
D69H, the mutant showing the largest difference in terms of C-alphaAV
compared to WT. On the other hand, M70V does not display any appre-
ciable difference compared to WT, thus conﬁrming the indications
obtained by the analysis of the sole C-alphaAV.
For the sake of completeness, Fig. 4b shows the computed cumula-
tive probabilities for WT and all the considered mutants: it is clear
that the curves computed for D69E(2) and D69H do overlap and strongly
diverge fromWT (shift of about 4 Å). In other words, the trajectories of
D69H and D69E suggest that a mutation in position 69 may turn away
T62 residues and induce a signiﬁcant diversion of loops A. In this re-
spect, it is worth saying that a value of distance b 27 Å is still found in
about 15% of the WT and M70V snapshots while it does not occur in
D69E(2) and D69H.
We notice also that the conformational state D69E(1) results from
the interaction, occurring at the monomer D, between K64, positively
charged and belonging to loop A, and the negatively charged mutated
residue, namely E69. This event is quite persistent for about 35 ns and
leads to the closure of loop A and, consequently, to a strong decrease
of the C-alpha distance (monomer A vs. monomer B) computed for
T62. For further information regarding the D69E(1) state the interested
reader is referred to Figs. S7 and S8 in the Supporting Information.3.2. Analysis of hydrogen bond interactions
To further investigate the diverse behaviors of WT and MTs, we
conducted a deep analysis of the hydrogen bond interactions occurring
in the tetramer within the simulated trajectories. Interestingly, the sole
appreciable difference was observed for threonine at position 56 (T56),
a residue belonging to loop A. Such ﬁnding supports again the hypoth-
esis that this extracellular loop is under the remote control of the single
point mutation at position 69. In this respect, Table 1 reports the rate of
Fig. 4. Distance distribution function (left) and cumulative probability (right) of C-alpha distances computed for residue T62. D69E(2) refers to data computed for the second conforma-
tional state of D69E.
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chain of T62 (donor) and the backbone of Leucine in position 53
(L53 — acceptor) during the entire analyzed trajectories.
The values in Table 1 indicate the percentage of frames in which the
hydrogen bond is formed, using as thresholds a distance atom acceptor
(AA)–atom donor (AD) equal to 3 Å and an angle AD–H–AA equal to
160°. In all considered MTs, such interaction occurs less frequently
with respect to WT and, again, the major difference is observed in the
case of D69E and D69H, being the corresponding percentages (22.72%
and 11.00% respectively) lower than WT (32.40%). On the other side,
data obtained from the trajectory of M70V (27.24%) are closer to WT.
Is it worth noting that such percentage was computed by assuming
that the four monomers behave independently, so that for each system
(i.e. WT and MTs) a trajectory equal to 95 ns × 4 was considered. Nev-
ertheless, the robustness of these data is conﬁrmed by the evidence
that the observed differences also occur considering each monomer
separately. Regarding D69H, for instance, the values obtained for mono-
mers A (10.62%), B (14.16%), C (10.16%) andD (9.06%) are all lowerwith
respect to those computed forWT, being equal to 31.96% (monomer A),
39.22% (B), 20.76% (C) and 37.64% (D). For the sake of clarity, represen-
tativeMD snapshots are shown in Fig. 5 to indicate the residues engaged
in hydrogen bond interactions for the WT and all MTs.
A further proof reinforcing the solidity of these data is given by
the time dependent evolutions of the distance between atom acceptor
(oxygen atom of the hydroxyl group of T56) and atom donor (oxygen
atom of the carbonyl of the backbone of L53). Fig. S2 (see supporting in-
formation) shows the results taking into account all the monomers of
WT and D69H: frames showing distances compatible with the H-bond
interactions are much less frequent in all the monomers of D69H with
respect to WT and the H-bond interaction, when it occurs, persists
only for a few nanoseconds. In summary, the analysis of the hydrogenTable 1
Occupancy (%) of the H-bond (donor–acceptor) occurring between the side chain of T62
and themain chain of L53 in the considered systems. An atom donor (AD)–atom acceptor
(AA)distance equal to 3Å and anangle AD–H–AAequal to 160°were usedas thresholds to
deﬁne the presence of the H-bond.
H-bond WT D69E D69H M70V
T56SIDE–L53BACKBONE 32.40 22.72 11.00 27.24bond interactions indicates that the conformational modiﬁcation of
the loop A, determined by the mutation at position 69, could be the re-
sult of the weakening of an interaction involving the residues T56 and
L53.3.3. Computation of the osmotic permeability
In a previous study [26], we found that two different gating mecha-
nisms can exist inside the water pore of WT. One is associated with the
well-known selectivity ﬁlter (SF) on the extracellular side (residues
H201 and R216); the other to the spontaneous reorientation of the im-
idazole ring of a histidine from loop B (H95) enabling an H-bond inter-
actionwith a cysteine belonging to the loopD (C178) at the cytoplasmic
end (CE). Notably, two different local constriction indicators (LCIs)were
deﬁned: 1) dSF, which measures the distance between the nitrogen
hydrogen bond (HB)-acceptor atom of H201 and the closer terminal
nitrogen atom of R216 at the selectivity ﬁlter (SF); 2) dCE, which mea-
sures the distance between the nitrogen HB-acceptor atom of H95 and
the sulfur atom of C178 at the CE. Based on the time evolution of the
LCIs, 4 different representative segments of trajectory were selected
and for each of them the total osmotic permeability was computed in
order to evaluate how it can be related to the different states, namely
open/open, open/closed, closed/open and closed/closed (following the
scheme SF/CE).
Herein, we extend this analysis to all the investigatedMTs. However,
as forWT, variations at the level of SF are quite rare and evenwhen they
occur, the closed state rapidly switches back to the open one. For the
sake of simplicity, the states herein considered were therefore those
open/open and open/closed. The results are shown in Table 2 while
the time dependent evolutions of dCE for all the considered systems
are given in Figs. S3–S6 (see Supporting Information).
In all the considered systems, the gatingmechanism at the cytoplas-
mic end affects heavily the permeability of the pore, with a decrease of
pf, resulting from the closure of CE, in the order of about 70%. Further-
more, the values computed for all the MTs, considering both open and
closed states, are in good agreement with those obtained for WT. In
other words, these data suggest that although the mutation D69 can
strongly affect the epitope formation, it does not have any effect in
terms of AQP4 water channel properties. Remarkably, these results
are in full agreement with recent experimental observations [25].
Fig. 5. Selected frames showing theH-bond interaction involving the side chain of T56 and the backbone of L53 inWT andM70V and the putative interaction between T56 and E69 present
in D69E and between T56 and H69 present in D69H.
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With the aim to target the AQP4 protein with small-molecules and
look for potentially active blockers,we searched for all the potential cav-
ities that are present in theAQP4 crystal structure (PDB code 3GD8) [16]
with the FLAPsite algorithm. As shown in Fig. 6, the sole cavity predicted
is located in the neighborhood of loop A. This observation suggests that
this regionwould be suitable for accommodating small-molecules, ther-
apeutically important, to prevent antibody binding.
Further investigations of the potential druggability of this site were
performed using molecular interaction ﬁelds (MIF)-based descriptors.
As shown in Fig. 7a, the AQP4 cavity (blue dot) falls in themost populat-
ed range of volume, surface, rugosity, and globularity distributions of
druggable active sites datasetmade of 43 X-ray solved pharmaceutically
relevant targets [48]. Furthermore, the computation of the interaction
descriptors (hydrophobic, hydrophilic and charge–charge/polar inter-
actions) revealed that the AQP4 cavity interaction values were againTable 2
Osmotic permeabilities (pf) computed for WT and all MT forms of the representative
segments of the trajectory corresponding to different states (open and closed) of the CE
region. All data are reported in 10−14 cm3/s unit.
System Status (CE)
Open Closed
WT 9.5 ± 2.1 2.5 ± 0.9
D69E 8.7 ± 2.5 2.3 ± 0.9
D69H 8.2 ± 3.2 2.6 ± 1.8
M70V 11.8 ± 2.1 2.1 ± 0.9in the same range of the reference druggable dataset, falling in themax-
imum distribution range (see Fig. 7b).
4. Discussion
Collectively, our results indicate that D69 is a key element for the re-
mote control of the loop A conformation of AQP4 and, more speciﬁcally,
for pushing residue T62 in or out of the lumen pore. The analysis of the
95 ns-long trajectories of WT, D69E, D69H and M70V suggest that sub-
stantial modiﬁcations at the level of loop A with respect to WT can beFig. 6. Cavity identiﬁed in the AQP4 crystal structure (PDB entry: 3GD8) by the FLAPsite
algorithm.
Fig. 7. Distributions of the Volsurf: (a) size and shape and (b) interaction descriptors for the active sites of the druggable reference set and position of AQP4 cavity (blue dots).
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the analysis of the computed osmotic permeabilities does not return
any appreciable difference when comparing WT and MTs. These ob-
servations match recent experimental ﬁndings whereby the consid-
ered mutants do not affect AQP4 water channel properties [25]. The
mutation of D69 has instead dramatic effects on all NMO-IgG epi-
topes. As experimentally observed, the NMO-IgG binding is ham-
pered mainly when the aspartate at position 69 is replaced by
histidine. No effects on NMO-IgG binding were instead observed
for the M70V case. Actually, our MD studies conﬁrm a substantial
overlap of theM70VmutantwithWT,with respect to the conformations
assumed by loop A. The good match between theoretical end experi-
mental data allows us to speculate on the features of the conformational
epitope.
More speciﬁcally, it can be reasonably assumed that, in WT and
M70V, NMO-IgG binding can be ensured by a speciﬁc conformation of
T62 that is able to protrude inside the central pore lumen in a kind of
“closed conformation”, which is forbidden to D69E and D69H having a
higher propensity to equilibrate in a kind of “open conformation”,
thus disrupting the conformational epitope.
Moreover, the analysis of the H-bond interactions conﬁrms the in-
volvement of the loop A. Indeed, a substantial difference in terms of
H-bond occurrence was observed betweenWT and the MTs. This inter-
action involves the hydroxyl group of T56 acting as H-bond donor and
the carbonyl group of the backbone of L53 acting as H-bond acceptor.
It should be noted that T56 belongs to loop A while L53 is part of the
ﬁrst transmembrane segment, named TM1. Furthermore, although the
mutated residue is at position 69, T56 is located at the base of the loop
A, having an adjacent residue belonging to a transmembrane region.
As clearly shown in Fig. 5, the effect of mutations at position 69 is that
of rotating the sidechain of T56 with the consequent disruption of the
interaction T56SIDE–L53MAIN to favor the hydrogen bond engagement
with the side chain of the glutamate or of the histidine in position 69.
This becomes even clearer if we consider the average distances computed
from the center of mass of the side chain, hereafter termed as CoMAV,
instead of CalphaAV. In fact, considering the mutated residue D69H, we
observe an increase in the CoMAV value N3 Å when compared to WT
(14.74 Å vs. 11.50 Å), thus conﬁrming a net trend for MTs to place the
mutated residue towards T56.
Taken together, these results indicate that the effect of the D69 mu-
tation consists in altering the loop A conformation and in particular the
spatial position of T62. Interestingly, here we ﬁrst report that such a
conformational modiﬁcation is the result of upstream weakening of
the hydrogen bond interaction T56SIDE–L53BACKBONE. This event is, in
turn, due to the higher propensity of the side chain of the mutated
residue at position 69 to attract the side chain of T56. As mentioned
above, our herein presented hypothesis is supported by experimental
literature [25,52]. In particular Miyazaki et al. [52] conclude not only
that the “replacement of loop A drastically reduces the binding of the
antibodies to human AQP4” but also that, among the other residues,
“T62 and/or L64 are involved in the epitope of the monoclonal antibod-
ies”. The epitope molecular features are recognition elements essential
to address the design of modulators of the NMO-IgG AQP4 binding.
This is a topic of extreme interest being AQP4 druggability [53] yet to
demonstrate. It is well known that druggability studies are indeed im-
portant to evaluate the likelihood that small drug-like molecules bind
a given target [54,55]. Indeed, an obstacle in the development of efﬁ-
cient AQP4 blockers might be due to the extreme difﬁculty to identify
cavities that would be large enough to accommodate possible drug-
like small-molecules. In this respect, we ﬁrst considered the chance to
detect cavities in the AQP4 surface by using FLAPsite and then we
assessed their suitableness for the binding of small-molecules by com-
parison with a dataset of druggable active sites [48]. Using the FLAPsite
algorithm [34] the entire surface of the AQP4 crystal structure (PDB
entry: 3GD8) was scanned looking for suitable molecular cavities. We
found only a putative binding site at the top of the channel locatedclose to loop A (see Fig. 6). The druggability of such potential binding
site was, thus, assessed by a knowledge-based approach. Using MIF-
based descriptors, the chemical–physical properties of the AQP4 cavity
were compared with those of well-known druggable active sites. As
shown in Fig. 7, the chemical–physical properties of the AQP4 cavity
are in the same range of the druggable reference dataset. More impor-
tantly, the AQP4 cavity intercepted, among the distribution ranges of
the size, shape and interaction descriptors, the highest populated bins.
Such knowledge-based observation discloses an intriguing scenario
and, to some extent, prompts us to hypothesize that AQP4 could be con-
sidered as a druggable target. Interestingly, MD studies and experimen-
tal evidences univocally indicate that loop A is important for NMO-IgG
binding; in addition the FLPAsite algorithm suggests that a binding
pocket for drug-like small-molecules is at the base of this loop. To the
best of our knowledge, the sole small-molecules ever demonstrating
an appreciable inhibition of NMO-IgG binding to AQP4 in NMO patient
sera are arbidol, tamarixetin and berbamine (see Fig. 8). In this respect,
we refer to the paper of Tradtrantip et al. [56] reporting, for these three
compounds, classical docking simulations focused into a region ﬂanked
by residues at the base of loop A (namely I57, N58 and V68). Retrospec-
tively, this region discloses a substantial overlap with the AQP4 cavity
identiﬁed by FLAPsite. On the basis of MD studies indicating that loop
A experiences a conformational change after mutating the aspartate at
position 69 (whose main effect was that of preventing NMO-IgG bind-
ing without affecting water permeability), we carried out induced ﬁt
docking (IFD) simulations enabling the ligand to determine conforma-
tional changes of the residues forming the AQP4 cavity, designated as
a receptor active site.
The top scoring poses obtained for arbidol, tamarixetin and
berbamine are shown in Fig. 8. Importantly, the lowest-energy docked
conformations were found at the loop A and almost completely inside
our AQP4 cavity. We notice that a very large docking box (side equal
to 26 Å, by default) was used in order to take into account possible
interactions with other extracellular loops. Consistently with the inves-
tigation of Trandtrip et al. [56] the compounds projected toward a hy-
drophobic cavity between the two transmembrane regions connected
by loopA. However, here, the use of an IFD protocol allowed us to obtain
several important additional clues. Arbidol and tamarixetin establish a
strong H-bond interaction with D69, whose side chain changes its con-
formation with respect to the crystal (see zoom in Fig. 8). Along with
D69, also L72 andW59 change their conformation in order tomaximize
a hydrophobic and an aromatic–aromatic interaction respectively.
Moreover, both ligands engage an H-bond interaction with the back-
bone of W59 whereas in the case of tamarixetin an additional interac-
tion with N58 is also found. In this respect, IFD calculations enrich the
observations coming fromMD and FLAPsite, complementing thosemo-
lecular analyses. Taken together, our study indicates that the identiﬁed
AQP4 cavity has the desirable physico-chemical proﬁle as well as the
suitable room to bind drug-like molecules.5. Conclusions
The present paper reports how the harmonized use of advanced bio-
physical and drug discovery strategies, already proved to be valuable for
other aquaporins [57], allow in approaching very challenging targets as
AQP4. Supported by very recent experimental observations [25,56], we
suggest that the surface of loop A and, more importantly, of the residues
ﬂanking its basis forms a druggable cavity and, thus, a valuable target for
the structure-based design of compounds able to inhibit NMO-IgG
binding to AQP4 in NMO patients. At present, we are screening the
entire Protein Data Bank searching for reliable cross-relationships with
known targetable proteinswith the aim todiscover newNMO-IgG bind-
ing blockers. This ongoing attempt might help to address future design
of small-molecule modulators and to plan rational drug repurposing
strategies.
Fig. 8. Sketches and top scoring docking poses of arbidol, tamarixetin and berbamine.
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